Endocrine system diseases

Test your knowledge of diabetes

This CPD and learning quiz can help you assess your knowledge of a range of diabetes topics, from insulin initiation to complications such as diabetic ketoacidosis.…

Almost one-third of people on low-calorie diet programme in remission from type 2 diabetes mellitus, study results show

Since its nationwide roll-out in May 2024, NHS England says more than 25,000 people have been referred to take part in the ‘Type 2 diabetes path to remission programme’.…

Seven in ten pharmacists say medicines shortages have put patients at risk in past six months

Exclusive: Responding to a survey of 1,265 UK-based pharmacists working in all sectors, 861 answered ‘Yes’ when asked if medicines shortages have put patients at risk “in the past six months”.…

Semaglutide linked to sight-threatening eye condition, study results suggest

Researchers used data from nearly 17,000 patients to examine whether semaglutide prescriptions were associated with increased risk of non-arteritic anterior ischemic optic neuropathy in patients with type 2 diabetes mellitus, obesity, or who were overweight.…

Number of patients at risk of type 2 diabetes increases by half a million in one year

Data from the National Diabetes Audit Programme show a 25% increase in adults aged under 40 years who were at risk of type 2 diabetes between 2022 and 2023.…

Diabetic ketoacidosis in adults: identification, diagnosis and management

All healthcare professionals who support people with diabetes should be aware of this complex medical emergency so that they can recognise red flag symptoms.…

Semaglutide lowers risk of kidney failure and cardiovascular death in patients with type 2 diabetes and CKD, study results show

Experts say this is an “important trial in patients with type 2 diabetes mellitus”, offering the possibility of semiglutide as an additional treatment option for slowing the progression of chronic kidney disease.…

Early intensive glycaemic control in type 2 diabetes provides near-lifelong protection, study finds

Study results showed the overall risk of death from any cause was reduced by 10–20% in participants with type 2 diabetes mellitus treated with intensive glycaemic control.…

Weight loss treatment programme for type 2 diabetes to be available across England

The programme shows “early promise” that it leads to remission of type 2 diabetes in up to half of participants after a year, according to NHS England.…

EMA finds no link between GLP-1 receptor agonists and suicidal thoughts

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee has confirmed that no update to product information is warranted.…